Developer docs
API playgroundTry for free, no card

Search company profiles

KSK

Full company profile

uuid000xhjc

Namestring
KSK
Legal namestring
株式会社ケーエスケー
Websiteurl
web-ksk.co.jp
Company typeenum
Private
Founded yearint
1962
Descriptiontext

KSK Co., Ltd. (株式会社ケーエスケー) is a private medical comprehensive trading company (医療総合商社) headquartered in Osaka, Japan, founded in 1962. The company operates six core business segments: pharmaceutical wholesale, nursing care products, medical devices/reagents/food, vaccine distribution, clinic opening support, and femtech. It serves hospitals, medical clinics, pharmacies, and nursing care facilities across the Kansai region (Osaka, Kyoto, Hyogo, Shiga, Nara, and Wakayama prefectures) through a direct sales force and an integrated logistics network comprising GDP-compliant distribution centers in Hyogo, Kyoto, and Osaka. The Hyogo Logistics Center was awarded ISO9001 certification in November 2024 and operates a 608.7 kW self-consumption solar power system reducing CO2 emissions by approximately 249 tons annually.

KSK generates revenue primarily through transaction-based B2B wholesale distribution of pharmaceutical, medical device, and nursing care products, supplemented by professional services (clinic opening support) and e-commerce (femtech video sales via L-Care Store). The company operates three wholly owned subsidiaries (Vital KSK, HMI, and Vital Net) and is expanding its digital ecosystem through the Tsunagu TV video platform (launched December 2025) for healthcare professional networking and the Arukana Mill customer portal (launched May 2025). KSK maintains extensive local government partnerships across the Kansai region covering community health promotion, cancer screening awareness, and elderly care initiatives. The company has been consecutively certified as a Health Management Excellent Corporation (健康経営優良法人) from 2023 through 2026.

In December 2025, KSK completed the acquisition of Yachiyo Care Holdings Co., Ltd. as a consolidated subsidiary, signaling vertical expansion into nursing care services. The company also entered a strategic collaboration with Hitachi in September 2025 to pursue digital transformation of pharmaceutical delivery operations. KSK employs between 1,001 and 5,000 people and remains privately held with no disclosed parent company or public listing.

Short descriptiontext

KSK Co., Ltd. (株式会社ケーエスケー) is a private Osaka-based medical comprehensive trading company, founded in 1962, that distributes pharmaceuticals, medical devices, nursing care products, and vaccines to hospitals, clinics, and pharmacies across Japan's Kansai region, complemented by femtech and clinic opening support services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersOsaka, Japan
HQ citystring
Osaka
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical wholesale, medical device distribution, healthcare logistics, nursing care supply, vaccine distribution
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Wholesale Distribution
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model6 records
1Pharmaceutical Wholesale
TypeTransaction Fee
Description

Distribution of pharmaceutical products to hospitals, clinics, and pharmacies across the Kansai region (Osaka, Hyogo, Kyoto, Shiga, Nara, Wakayama)

web-ksk.co.jp
2Nursing Care Products
TypeTransaction Fee
Description

Supply of nursing care and welfare products to healthcare and care facilities

web-ksk.co.jp
3Medical Devices, Reagents, and Food Products
TypeTransaction Fee
Description

Wholesale distribution of medical devices, reagents, and food products to healthcare providers

web-ksk.co.jp
4Vaccine Distribution
TypeTransaction Fee
Description

Specialized vaccine distribution services

web-ksk.co.jp
5Clinic Opening Support
TypeProfessional Services
Description

Consulting and support services for medical clinic establishment and开业

web-ksk.co.jp
6Femtech
TypeOthers
Description

Femtech and femcare video sales e-commerce services

web-ksk.co.jp
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Supply Chain, Personnel, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 6 records shown
1Vital KSK
Description

Healthcare services subsidiary brand operated by KSK Co., Ltd.

web-ksk.co.jp
+5 more records
Core offering1 text field

KSK is a medical comprehensive trading company (医療総合商社) that distributes pharmaceutical products, medical devices, reagents, vaccines, and nursing care products to hospitals, clinics, and pharmacies across the Kansai region of Japan. The company also offers clinic opening support services and femtech/femcare products, supported by a regional logistics network of GDP-compliant distribution centers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

KSK is a medical comprehensive trading company (医療総合商社) operating primarily in the Kansai region of Japan. The company operates as a multi-business portfolio consisting of six core business segments: Pharmaceutical Wholesale (医薬品卸売), Nursing Care Products (介護用品), Medical Devices/Reagents/Food (医療機器・試薬・食品), Vaccine Business (ワクチン), Clinic Opening Support (医院開業支援), and Femtech (フェムテック). These businesses are supported by a network of three subsidiaries (Vital KSK, HMI, and Vital Net) and delivered through digital service platforms including the Tsunagu TV video platform for medical/health information, the L-Care Store femcare e-commerce site, and the Arukana Mill customer portal. The company also maintains logistics centers in Hyogo, Kyoto, and Osaka for distribution operations.

Product and service2 records
1Pharmaceutical Wholesale (医薬品卸事業)
CategoryPharmaceutical Distribution
Description

Pharmaceutical wholesale distribution business supplying medicines to hospitals, clinics, and pharmacies across the Kansai region.

2Nursing Care Products (介護用品事業)
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierMinorTypeOthersAnnounced on2025-12-25
Description

Comprehensive partnership agreement covering health promotion, cancer screening, lifestyle disease prevention, infectious disease measures, nutrition education, elderly care prevention, elderly and child monitoring, and collaborative community development

2丹波市
Strategic tierMinorTypeOthersAnnounced on2025-12-22
Description

Partnership for community health promotion, cancer screening awareness, lifestyle disease prevention, nutrition education, infectious disease measures, and collaborative community development

web-ksk.co.jp
3八千代ケアホールディングス株式会社
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-12-01
Description

Subsidiary acquisition to expand nursing care and healthcare service offerings

web-ksk.co.jp
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-09-10
Description

Collaboration with Hitachi on DX (digital transformation) for pharmaceutical delivery operations. Partnership focuses on modernizing logistics and delivery processes using digital technologies.

5富田林市
Strategic tierMinorTypeOthersAnnounced on2025-05-20
Description

Comprehensive partnership agreement for community health promotion and regional development

web-ksk.co.jp
Strategic tierMinorTypeOthersAnnounced on2023-07-04
Description

Partnership for cancer control promotion with Wakayama City

7神戸市
Strategic tierMinorTypeOthersAnnounced on2022-12-09
Description

Agreement for citizen health promotion and education cooperation with Kobe City

web-ksk.co.jp
8株式会社ナナハネクサス
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-10-03
Description

Business partnership for logistics center operations. Mutual development to maximize customer service, with particular focus on cooperation for logistics function recovery during emergencies to ensure stable supply capabilities.

web-ksk.co.jp
Strategic tierMinorTypeOthersAnnounced on2021-06-24
Description

Elderly-friendly regional development promotion agreement with Osaka Prefecture

10京都市
Strategic tierMinorTypeOthersAnnounced on2021-03-02
Description

Partnership for 'Healthy Long-Life City Kyoto' promotion and cancer screening rate improvement

web-ksk.co.jp
11個別化医療・医薬品トレーサビリティ協議会
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-02-22
Description

Participation in the Personalized Medicine and Pharmaceutical Traceability Council to contribute to drug traceability initiatives

web-ksk.co.jp
Strategic tierMinorTypeOthersAnnounced on2020-08-07
Description

Partnership for Osaka Prefecture citizen health promotion, cancer screening awareness, and health promotion platform development

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Major national pharmaceutical wholesaler formed through the merger of Alfresa and Mediceo Suzuken predecessors. Competes head-to-head with KSK in Kansai hospital and pharmacy supply, with broader scale and additional medical device and consumer healthcare businesses.

TypeDirect peer
Description

Major pharmaceutical wholesaler that merged into the Medipal Holdings structure. Closely aligned with KSK in pharmaceutical distribution to hospitals, clinics, and pharmacies across Japan, particularly comparable in Kansai regional coverage.

TypeBroad incumbent
Description

National pharmaceutical wholesaler group operating across Japan with focus on hospital channel distribution. Directly comparable to KSK's hospital pharmaceutical distribution business and competes in Kansai accounts.

TypeBroad incumbent
Description

Diversified Japanese trading company (sogo shosha) with a healthcare segment covering pharmaceutical distribution and medical materials. Comparable to KSK as a multi-segment medical business operator, though at far greater scale and with industrial chemicals exposure.

TypeDirect peer
Description

Pharmaceutical and medical device wholesaler operating primarily in the Kansai and western Japan regions. Most directly comparable to KSK in regional footprint and product mix, with comparable hospital/clinic/pharmacy customer base.

TypeRegional player
Description

Mid-sized pharmaceutical wholesaler primarily serving the Shikoku and western Japan regions. Comparable to KSK as a regional medical trading company with overlapping Kansai-area customer segments and product portfolio.

TypeBroad incumbent
Description

Japan's largest pharmaceutical wholesaler with national coverage across all prefectures, including a strong Kansai presence. Directly comparable to KSK in pharmaceutical distribution but at vastly greater scale, with diversified business including Mediceo and Paltac.

TypeRegional player
Description

Regional pharmaceutical wholesaler serving the Kanto and other regions with medical and nursing care products. Directly comparable to KSK as a multi-segment medical trading company with regional focus.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

KSK

Pharmaceutical Wholesale Distributionweb-ksk.co.jp

KSK Co., Ltd. (株式会社ケーエスケー) is a private Osaka-based medical comprehensive trading company, founded in 1962, that distributes pharmaceuticals, medical devices, nursing care products, and vaccines to hospitals, clinics, and pharmacies across Japan's Kansai region, complemented by femtech and clinic opening support services.

What KSK does

KSK Co., Ltd. (株式会社ケーエスケー) is a private medical comprehensive trading company (医療総合商社) headquartered in Osaka, Japan, founded in 1962. The company operates six core business segments: pharmaceutical wholesale, nursing care products, medical devices/reagents/food, vaccine distribution, clinic opening support, and femtech. It serves hospitals, medical clinics, pharmacies, and nursing care facilities across the Kansai region (Osaka, Kyoto, Hyogo, Shiga, Nara, and Wakayama prefectures) through a direct sales force and an integrated logistics network comprising GDP-compliant distribution centers in Hyogo, Kyoto, and Osaka. The Hyogo Logistics Center was awarded ISO9001 certification in November 2024 and operates a 608.7 kW self-consumption solar power system reducing CO2 emissions by approximately 249 tons annually.

KSK generates revenue primarily through transaction-based B2B wholesale distribution of pharmaceutical, medical device, and nursing care products, supplemented by professional services (clinic opening support) and e-commerce (femtech video sales via L-Care Store). The company operates three wholly owned subsidiaries (Vital KSK, HMI, and Vital Net) and is expanding its digital ecosystem through the Tsunagu TV video platform (launched December 2025) for healthcare professional networking and the Arukana Mill customer portal (launched May 2025). KSK maintains extensive local government partnerships across the Kansai region covering community health promotion, cancer screening awareness, and elderly care initiatives. The company has been consecutively certified as a Health Management Excellent Corporation (健康経営優良法人) from 2023 through 2026.

In December 2025, KSK completed the acquisition of Yachiyo Care Holdings Co., Ltd. as a consolidated subsidiary, signaling vertical expansion into nursing care services. The company also entered a strategic collaboration with Hitachi in September 2025 to pursue digital transformation of pharmaceutical delivery operations. KSK employs between 1,001 and 5,000 people and remains privately held with no disclosed parent company or public listing.

KSK firmographics

Firmographics
Name
KSK
Legal name
株式会社ケーエスケー
Website
https://web-ksk.co.jp
Company type
Private
Founded year
1962
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
KSK Co., Ltd. (株式会社ケーエスケー) is a private Osaka-based medical comprehensive trading company, founded in 1962, that distributes pharmaceuticals, medical devices, nursing care products, and vaccines to hospitals, clinics, and pharmacies across Japan's Kansai region, complemented by femtech and clinic opening support services.
Ownership category
akta.pro rank

Where KSK is headquartered

Location

Headquarters

HQ city
Osaka
HQ country
Japan
HQ region
Asia

Offices5 records

Markets served

KSK business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Personnel, Operations, Infrastructure

Revenue model

  1. Pharmaceutical Wholesale: Distribution of pharmaceutical products to hospitals, clinics, and pharmacies across the Kansai region (Osaka, Hyogo, Kyoto, Shiga, Nara, Wakayama)
  2. Nursing Care Products: Supply of nursing care and welfare products to healthcare and care facilities
  3. Medical Devices, Reagents, and Food Products: Wholesale distribution of medical devices, reagents, and food products to healthcare providers
  4. Vaccine Distribution: Specialized vaccine distribution services
  5. Clinic Opening Support: Consulting and support services for medical clinic establishment and开业
  6. Femtech: Femtech and femcare video sales e-commerce services

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

KSK product offering

Product offering

Core offering

KSK is a medical comprehensive trading company (医療総合商社) that distributes pharmaceutical products, medical devices, reagents, vaccines, and nursing care products to hospitals, clinics, and pharmacies across the Kansai region of Japan. The company also offers clinic opening support services and femtech/femcare products, supported by a regional logistics network of GDP-compliant distribution centers.

Product overview

KSK is a medical comprehensive trading company (医療総合商社) operating primarily in the Kansai region of Japan. The company operates as a multi-business portfolio consisting of six core business segments: Pharmaceutical Wholesale (医薬品卸売), Nursing Care Products (介護用品), Medical Devices/Reagents/Food (医療機器・試薬・食品), Vaccine Business (ワクチン), Clinic Opening Support (医院開業支援), and Femtech (フェムテック). These businesses are supported by a network of three subsidiaries (Vital KSK, HMI, and Vital Net) and delivered through digital service platforms including the Tsunagu TV video platform for medical/health information, the L-Care Store femcare e-commerce site, and the Arukana Mill customer portal. The company also maintains logistics centers in Hyogo, Kyoto, and Osaka for distribution operations.

Differentiator

Problem solved

Functional benefit

Brands

  • Vital KSK: Healthcare services subsidiary brand operated by KSK Co., Ltd.
  • HMI
  • Vital Net
  • つなぐTV
  • エルケアストア
  • Arukana Mill

Products and services

  • Pharmaceutical Wholesale (医薬品卸事業) Pharmaceutical wholesale distribution business supplying medicines to hospitals, clinics, and pharmacies across the Kansai region.
  • Nursing Care Products (介護用品事業)

Companies that use KSK

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

KSK technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

KSK partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered minor and core.

  • 相生市minorOthers · 25 December 2025Comprehensive partnership agreement covering health promotion, cancer screening, lifestyle disease prevention, infectious disease measures, nutrition education, elderly care prevention, elderly and child monitoring, and collaborative community development
  • 丹波市minorOthers · 22 December 2025Partnership for community health promotion, cancer screening awareness, lifestyle disease prevention, nutrition education, infectious disease measures, and collaborative community development
  • 八千代ケアホールディングス株式会社minorStrategic or Co-development Partner · 1 December 2025Subsidiary acquisition to expand nursing care and healthcare service offerings
  • Hitachi (日立)coreTechnology or Integration · 10 September 2025Collaboration with Hitachi on DX (digital transformation) for pharmaceutical delivery operations. Partnership focuses on modernizing logistics and delivery processes using digital technologies.
  • 富田林市minorOthers · 20 May 2025Comprehensive partnership agreement for community health promotion and regional development
  • 和歌山市minorOthers · 4 July 2023Partnership for cancer control promotion with Wakayama City
  • 神戸市minorOthers · 9 December 2022Agreement for citizen health promotion and education cooperation with Kobe City
  • 株式会社ナナハネクサスcoreStrategic or Co-development Partner · 3 October 2022Business partnership for logistics center operations. Mutual development to maximize customer service, with particular focus on cooperation for logistics function recovery during emergencies to ensure stable supply capabilities.
  • 大阪府minorOthers · 24 June 2021Elderly-friendly regional development promotion agreement with Osaka Prefecture
  • 京都市minorOthers · 2 March 2021Partnership for 'Healthy Long-Life City Kyoto' promotion and cancer screening rate improvement
  • 個別化医療・医薬品トレーサビリティ協議会minorStrategic or Co-development Partner · 22 February 2021Participation in the Personalized Medicine and Pharmaceutical Traceability Council to contribute to drug traceability initiatives
  • 大阪府minorOthers · 7 August 2020Partnership for Osaka Prefecture citizen health promotion, cancer screening awareness, and health promotion platform development

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

KSK competitors and assessment

Company assessment

Broad incumbents

  • Alfresa Holdings Corporation: Major national pharmaceutical wholesaler formed through the merger of Alfresa and Mediceo Suzuken predecessors. Competes head-to-head with KSK in Kansai hospital and pharmacy supply, with broader scale and additional medical device and consumer healthcare businesses.
  • Toho Holdings Co., Ltd. National pharmaceutical wholesaler group operating across Japan with focus on hospital channel distribution. Directly comparable to KSK's hospital pharmaceutical distribution business and competes in Kansai accounts.
  • Nagase & Co., Ltd. Diversified Japanese trading company (sogo shosha) with a healthcare segment covering pharmaceutical distribution and medical materials. Comparable to KSK as a multi-segment medical business operator, though at far greater scale and with industrial chemicals exposure.
  • Medipal Holdings Corporation: Japan's largest pharmaceutical wholesaler with national coverage across all prefectures, including a strong Kansai presence. Directly comparable to KSK in pharmaceutical distribution but at vastly greater scale, with diversified business including Mediceo and Paltac.

Direct peers

  • Suzuken Co., Ltd. Major pharmaceutical wholesaler that merged into the Medipal Holdings structure. Closely aligned with KSK in pharmaceutical distribution to hospitals, clinics, and pharmacies across Japan, particularly comparable in Kansai regional coverage.
  • Yoshida & Co., Ltd. Pharmaceutical and medical device wholesaler operating primarily in the Kansai and western Japan regions. Most directly comparable to KSK in regional footprint and product mix, with comparable hospital/clinic/pharmacy customer base.

Regional players

  • Iwaki & Co., Ltd. Mid-sized pharmaceutical wholesaler primarily serving the Shikoku and western Japan regions. Comparable to KSK as a regional medical trading company with overlapping Kansai-area customer segments and product portfolio.
  • Astena Corporation (formerly Sogo Medical Holdings): Regional pharmaceutical wholesaler serving the Kanto and other regions with medical and nursing care products. Directly comparable to KSK as a multi-segment medical trading company with regional focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

KSK compliance and trust

Trust signal

Compliance1 record

KSK financial estimates

Financial estimate

Revenue estimate

Valuation estimate

KSK leadership team

Management profile

Number of profiles

Profiles2 records

KSK subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

KSK funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

KSK M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KSK

What does KSK do?

KSK is a medical comprehensive trading company (医療総合商社) that distributes pharmaceutical products, medical devices, reagents, vaccines, and nursing care products to hospitals, clinics, and pharmacies across the Kansai region of Japan. The company also offers clinic opening support services and femtech/femcare products, supported by a regional logistics network of GDP-compliant distribution centers.

Is KSK a public or private company?

KSK is a private company. It is classified as unknown and is currently operating.

When was KSK founded?

KSK was founded in 1962. It employs 1,001 to 5,000 people.

Where is KSK based?

KSK is headquartered in Osaka, Japan, in the Asia region.

How does KSK make money?

Six revenue lines are on record. Pharmaceutical Wholesale is the primary driver. The others are nursing Care Products, medical Devices, Reagents, and Food Products, vaccine Distribution, clinic Opening Support and femtech.

Who are KSK's main competitors?

Broad incumbents on record are Alfresa Holdings Corporation, Toho Holdings Co., Ltd., Nagase & Co., Ltd. and Medipal Holdings Corporation. Direct peers are Suzuken Co., Ltd. and Yoshida & Co., Ltd.. Regional players are Iwaki & Co., Ltd. and Astena Corporation (formerly Sogo Medical Holdings).

Does KSK have an API?

No public API is recorded for KSK.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals